Atlas Trials

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma

Clinical trial NCT00245141 · UNKNOWN

Trial details

NCT number
NCT00245141
Sponsor
Japan Rhabdomyosarcoma Study Group
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
2004-05-01
Primary completion
2011-04-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.